These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19689309)

  • 21. Hypocretin administration as a treatment for human narcolepsy.
    Siegel JM
    Sleep; 2003 Dec; 26(8):932-3. PubMed ID: 14746368
    [No Abstract]   [Full Text] [Related]  

  • 22. Physiological arousal: a role for hypothalamic systems.
    Adamantidis A; de Lecea L
    Cell Mol Life Sci; 2008 May; 65(10):1475-88. PubMed ID: 18351292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The hypocretins/orexins: integrators of multiple physiological functions.
    Li J; Hu Z; de Lecea L
    Br J Pharmacol; 2014 Jan; 171(2):332-50. PubMed ID: 24102345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.
    Beuckmann CT; Yanagisawa M
    J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
    Hoyer D; Jacobson LH
    Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of hypocretins (orexins) in sleep regulation and narcolepsy.
    Taheri S; Zeitzer JM; Mignot E
    Annu Rev Neurosci; 2002; 25():283-313. PubMed ID: 12052911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hypothalamic peptidergic system, hypocretin/orexin and vigilance control.
    Nishino S
    Neuropeptides; 2007 Jun; 41(3):117-33. PubMed ID: 17376528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines.
    Hungs M; Fan J; Lin L; Lin X; Maki RA; Mignot E
    Genome Res; 2001 Apr; 11(4):531-9. PubMed ID: 11282968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding.
    Sutcliffe JG; de Lecea L
    J Neurosci Res; 2000 Oct; 62(2):161-8. PubMed ID: 11020209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of orexins and orexin receptors in central regulation of feeding behavior and energy homeostasis.
    Sakurai T
    CNS Neurol Disord Drug Targets; 2006 Jun; 5(3):313-25. PubMed ID: 16787231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response.
    Winsky-Sommerer R; Yamanaka A; Diano S; Borok E; Roberts AJ; Sakurai T; Kilduff TS; Horvath TL; de Lecea L
    J Neurosci; 2004 Dec; 24(50):11439-48. PubMed ID: 15601950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy.
    Mishima K; Fujiki N; Yoshida Y; Sakurai T; Honda M; Mignot E; Nishino S
    Sleep; 2008 Aug; 31(8):1119-26. PubMed ID: 18714784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.
    Fadel J; Burk JA
    Brain Res; 2010 Feb; 1314():112-23. PubMed ID: 19699722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A commentary on the neurobiology of the hypocretin/orexin system.
    Mignot E
    Neuropsychopharmacology; 2001 Nov; 25(5 Suppl):S5-13. PubMed ID: 11682267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs to interfere with orexins (hypocretins).
    Selbach O; Eriksson KS; Haas HL
    Drug News Perspect; 2003 Dec; 16(10):669-81. PubMed ID: 14747847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Narcolepsy genes wake up the sleep field.
    Takahashi JS
    Science; 1999 Sep; 285(5436):2076-7. PubMed ID: 10523205
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypocretins/orexins and narcolepsy: from molecules to disease].
    Peyron C; Charnay Y
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S35-41. PubMed ID: 14646798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypocretins: involvement in the regulation of sleep-wakefulness cycle and pathogenesis of narcolepsy].
    Berezińska M; Zawilska JB
    Postepy Hig Med Dosw (Online); 2007; 61():1-12. PubMed ID: 17245312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.
    Nishino S
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1785-97. PubMed ID: 17970638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.